Supplemental material
Open access
3,875
Views
30
CrossRef citations to date
0
Altmetric
Research Paper
Assessment of the potential public health impact of Herpes Zoster vaccination in Germany
Desmond CurranGSK, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0002-7423-0111
, https://orcid.org/0000-0002-7423-0111
Desirée Van OorschotGSK, Wavre, Belgium
, Lijoy VargheseGSK, Singaporehttps://orcid.org/0000-0002-6036-424X
, Lidia OostvogelsGSK, Wavre, Belgium
, Tomas MrkvanGSK, Wavre, Belgium
, Romulo ColindresGSK, Wavre, Belgium
, Alfred von KrempelhuberGSK, München, Germany
& Anastassia AnastassopoulouGSK, München, Germany
show all
Pages 2213-2221
|
Received 08 Mar 2017, Accepted 19 Jun 2017, Published online: 21 Sep 2017
Related Research Data
The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy
Source:
Informa UK Limited
Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster.
Source:
Springer Science and Business Media LLC
Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults
Source:
(:unav)
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
Source:
Informa UK Limited
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.